. Author manuscript; available in PMC: 2008 Jan 1.

Published in final edited form as: Am Heart J. 2007 Jan;153(1):104.e1–104.e7. doi: 10.1016/j.ahj.2006.10.003

TABLE 1.

Clinical Characteristics of the Patient Population

Demographics
Age (y)	50 ± 11
Height (m)	176.7 ± 7.7
Weight (kg)	87.7 ± 17.0
BMI (kg/m²)	28.0 ± 4.9
BSA (m²)	2.1 ± 0.2
LVEF (%)	18.3 ± 3.8
NYHA Class	Class III n=10 Class IV n=2
CHF Etiology (Ischemic/Idiopathic)	7 / 5
Medications
ACE Inhibitors	8 (66.7)
Angiotensin II Receptor Blockers	3 (25.0)
Aspirin	8 (66.7)
β-Blockers	7 (58.3)
Digitalis	10 (83.3)
Diuretics	12 (100)

ACE, angiotensin converting enzyme; BMI, body mass index; BSA, body surface area; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association. Data are presented as Mean±SD or as number of participants (percentage of population), n=12